Back to Authors

Scherrer, Emilie

https://orcid.org/0000-0003-3184-3724

A5091485339 | I1285764155

Mayo Clinic

Merck & Co., Inc., Rahway, NJ, USA (United States)

Citations 2

897 Infusion episode-related benefits of pembrolizumab Q6W dosing schedule for patients with melanoma treated in the adjuvant and metastatic settings in the United States (US)

Regular and Young Investigator Award Abstracts | November 9, 2021 | Volume: No volume available | Issue: No issue available | Pages: A941-A941

10.1136/jitc-2021-sitc2021.897

Hospitalization and emergency department utilization in patients with advanced melanoma receiving pembrolizumab versus ipilimumab plus nivolumab in US academic centers

Journal of Medical Economics | November 21, 2019 | Volume: 23 | Issue: 2 | Pages: 132-138

10.1080/13696998.2019.1696349 | PMID 31750751